Axsome Therapeutics Inc.

NASDAQ: AXSM · Real-Time Price · USD
109.20
0.45 (0.41%)
At close: Aug 15, 2025, 3:59 PM
108.99
-0.19%
After-hours: Aug 15, 2025, 04:57 PM EDT

Axsome Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
315.35M 386.19M 200.84M 86.47M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
19.11M 11.03M 14.72M 322.91K
Receivables
142M 94.82M 37.7M n/a
Inventory
15.73M 15.13M 4.32M n/a
Other Current Assets
11.98M 8.12M 2.78M n/a
Total Current Assets
485.06M 504.26M 245.64M 86.52M
Property-Plant & Equipment
5.38M 7.62M 1.14M 944.01K
Goodwill & Intangibles
58.94M 65.33M 69.97M n/a
Total Long-Term Assets
83.43M 83.97M 85.83M 1.27M
Total Assets
568.5M 588.24M 331.48M -338.36M
Account Payables
72M 40.68M 38.6M 13.15M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
157.15M 76.45M 5.9M n/a
Total Current Liabilities
230.1M 138.85M 96.56M 23.07M
Long-Term Debt
180.71M 178.07M 94.26M 49.09M
Other Long-Term Liabilities
100.67M 73.3M 31.1M n/a
Total Long-Term Liabilities
281.38M 258.4M 125.36M 49.09M
Total Liabilities
511.48M 397.26M 221.92M 70.84M
Total Debt
192.96M 186.37M 94.68M 49.71M
Common Stock
5K 5K 4.35K 3.78K
Retained Earnings
-1.12B -835.57M -596.33M -409.2M
Comprehensive Income
n/a 0.00 n/a 0.00
Shareholders Equity
57.02M 190.98M 109.56M -409.2M
Total Investments
n/a n/a n/a n/a